AstraZeneca PLC (AZN) Sentiment
SentiSense Score 3 · Neutral · ▲ rising · as of 2026-06-25
AZN sentiment is neutral (SentiSense Score 3, strengthening from a 30-day average of 14); attention is steady (6 mentions).
- Sentiment
- Neutral
- SentiSense Score
- 3
- Mentions
- 6
Sentiment by source
- News
- Bullish
- Bullish
- X
- Neutral
What's driving it
- AstraZeneca Expands Partnership with Korean Biotechs via Strategic Cooperation (+0.5)
- Novartis Introduces Pluvicto, India's First Approved Radioligand Therapy (+0.73)
- FDA Approves Capivasertib Combo for PTEN-Deficient Prostate Cancer (+0.37)
Live SentiSense Score, sentiment history, and per-source breakdown for AstraZeneca PLC on SentiSense.